Virtual ligand screening: strategies, perspectives and limitations

被引:502
作者
Klebe, Gerhard [1 ]
机构
[1] Univ Marburg, Inst Pharmaceut Chem, D-35032 Marburg, Germany
关键词
D O I
10.1016/j.drudis.2006.05.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In contrast to high-throughput screening, in virtual ligand screening (VS), compounds are selected using computer programs to predict their binding to a target receptor. A key prerequisite is knowledge about the spatial and energetic criteria responsible for protein-ligand binding. The concepts and prerequisites to perform VS are summarized here, and explanations are sought for the enduring limitations of the technology. Target selection, analysis and preparation are discussed, as well as considerations about the compilation of candidate ligand libraries. The tools and strategies of a VS campaign, and the accuracy of scoring and ranking of the results, are also considered.
引用
收藏
页码:580 / 594
页数:15
相关论文
共 128 条
[81]  
MOEBIUS FF, 2001, CURR MED CHEM, V8, P1035
[82]   Docking: Successes and challenges [J].
Mohan, V ;
Gibbs, AC ;
Cummings, MD ;
Jaeger, EP ;
DesJarlais, RL .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (03) :323-333
[83]   Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock® [J].
Morley, SD ;
Afshar, M .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2004, 18 (03) :189-208
[84]  
Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO
[85]  
2-B
[86]   Small Molecule Docking and Scoring [J].
Muegge, Ingo ;
Rarey, Matthias .
REVIEWS IN COMPUTATIONAL CHEMISTRY, VOL 17, 2001, 17 :1-60
[87]   Current trends in lead discovery: Are we looking for the appropriate properties? [J].
Oprea, TI .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (5-6) :325-334
[88]   Automated docking to multiple target structures:: Incorporation of protein mobility and structural water heterogeneity in AutoDock [J].
Österberg, F ;
Morris, GM ;
Sanner, MF ;
Olson, AJ ;
Goodsell, DS .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 2002, 46 (01) :34-40
[89]   Chris Lipinski discusses life and chemistry after the Rule of Five [J].
Owens, J ;
Lipinski, C .
DRUG DISCOVERY TODAY, 2003, 8 (01) :12-16
[90]   Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis [J].
Paiva, AM ;
Vanderwall, DE ;
Blanchard, JS ;
Kozarich, JW ;
Williamson, JM ;
Kelly, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2001, 1545 (1-2) :67-77